The production of unit for suppository forms of Sofia-based drug maker Sopharma has been operating at its full 12 mln package annual capacity since March 15, the Bulgarian stock exchange said on Monday, March 21. The production unit, the result of a 6 mln lev greenfield investment, meets all Good Manufacturing Practice standards and is licensed for the production of suppository forms by the Bulgarian Drug Agency.